Optiver Holding B.V. Harvard Bioscience Inc Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 14 shares of HBIO stock, worth $7. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$7% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
72Shares Held
21.3MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD4.05MShares$2.31 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.62 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$1.22 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$1.06 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$855,8590.03% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $23.7M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...